1. Stocks
  2. Trinity Biotech Plc - ADR
  3. Swot
swot-logo

Trinity Biotech Plc - ADR SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Trinity Biotech Plc - ADR has 6 Strengths, 17 Weaknesses, 1 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Significant (over 30%) distance from 52 week high

Rising Net Cash Flow and Cash from Operating activity

PEG lower than Industry PEG

Overbought by Money Flow Index (MFI)

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Stock with Low PE (PE < = 10)

Stocks with Quarter Change % less than Industry

New 52 week low today

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Highest fall from 52 Week High

MACD crossed below zero line previous end of day

Top Losers

Low Piotroski Score : Companies with weak financials

Book Value Per Share deteriorating for last 2 years

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Recent Results: Declining Operating Profit Margin and Net Profits (YoY)

RSI indicating price weakness

Near 52 Week Low

Top Losers

Stocks Underperforming their Industry Price Change in the Quarter

Institutions increasing their shareholding